Cite
Current state and upcoming opportunities for immunoPET biomarkers in lung cancer.
MLA
Slebe, Maarten, et al. “Current State and Upcoming Opportunities for ImmunoPET Biomarkers in Lung Cancer.” Lung Cancer (01695002), vol. 169, July 2022, pp. 84–93. EBSCOhost, https://doi.org/10.1016/j.lungcan.2022.05.017.
APA
Slebe, M., Pouw, J. E. E., Hashemi, S. M. S., Menke-van der Houven van Oordt, C. W., Yaqub, M. M., & Bahce, I. (2022). Current state and upcoming opportunities for immunoPET biomarkers in lung cancer. Lung Cancer (01695002), 169, 84–93. https://doi.org/10.1016/j.lungcan.2022.05.017
Chicago
Slebe, Maarten, Johanna E.E. Pouw, Sayed M.S. Hashemi, C. Willemien Menke-van der Houven van Oordt, Maqsood M. Yaqub, and Idris Bahce. 2022. “Current State and Upcoming Opportunities for ImmunoPET Biomarkers in Lung Cancer.” Lung Cancer (01695002) 169 (July): 84–93. doi:10.1016/j.lungcan.2022.05.017.